Industry: Bio-pharmaceutical Distribution, August 2006
Investment Type: Growth Capital
Company Description: Medison Biotech Ltd., founded in 1996, is a leading distributor and representative in Israel of global bio-pharmaceutical drug companies including Biogen Idec, Genzyme, Ipsen and Antigenics.
The Company markets its products directly to health funds (HMO's), hospitals, governmental institutions and private pharmacies. Medison's founders have been in the Israeli drug distribution business for more than twenty years and its highly experienced management team combines academic backgrounds with many years experience in the local and international pharmaceutical industry. The prescription drug market in Israel has grown substantially and the Company has experienced solid growth over the past three years. In addition, Medison's strong relationships with its suppliers and proven track record in Israel may facilitate the Company's growth in other markets.
Transaction: Shamrock has invested in Medison via a structured transaction which includes shares, notes and options.
